TEL AVIV, Israel, May 22, 2025 /PRNewswire/ -- Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical...
SANTA CLARA, Calif., March 24, 2025--(BUSINESS WIRE)--Oklo Inc. (NYSE: OKLO) ("Oklo" or "the Company"), an advanced nuclear technology company, today...
Adocia (Euronext Paris: FR0011184241 – ADOC, the "Company"), a clinical-stage biopharmaceutical company focused on the research and development of innovative...
2024 Financial and Product Development Objectives Met; Focus Turns to Securing Customers for 2025SALT LAKE CITY, February 20, 2025--(BUSINESS WIRE)--Palladyne...
Major US equity markets declined last week as last weekend’s tariff announcements continued to be digested, writes Ian Slattery. Ian...
Jerome Powell might have sighed with relief as the spotlight was taken away from the Fed’s announcement last week, writes...
